could get a license to make the pill for export to other countries, the medicine could not be made generically for use in Brazil.
He estimated that other drugmakers would be able to start producing the pill within months, but acknowledged the agreement wouldn’t please everyone. and will waive royalties on sales in all countries covered by the agreement while Covid-19 remains a public health emergency.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer agrees to let other companies make its COVID-19 pillLONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. mikewsyx6 I ran across a documentary called 'Covid-19, Race for the Vaccine' about Pfizer's efforts to get the vaccine out. It's well worth watching. Glad they're willing to share this new pill to help people, not their bottom line. kxly4news This is all turning out to be very lucrative for pfizer. Good thing they got all that money and support from Operation Warp Speed huh? Thank you pfizer
Lire la suite »
Pfizer agrees to let other companies make its COVID-19 pillDrugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world’s population. “It’s quite significant that we will be able to provide access to a drug that appears to be effective and has just been developed, to more than 4 billion people,” Esteban Burrone, head of policy at the Medicines Patent Pool, said.
Lire la suite »